Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 55 for “"Endocrine Resistance"”.
-
The role of metabolic rewiring in endocrine resistance
… occur due to metastases that are resistant to endocrine therapy. There is a critical need for novel therapeutic approaches to prevent or delay recurrence of ERα (+) tumors. The overall objective of this dissertation project is to define the interaction among endocrine resistance, nuclear export …
-
ESR1 mutations and endocrine resistance in human breast cancer
… domain (LBD) of ESR1 have been identified as a resistance mechanism in patients who have progressed on endocrine therapies. In order to better understand the clinical significance of these mutations, two novel approaches for studying ESR1 activating mutations were developed. First, we …
-
Downstream targets of the oestrogen receptor and endocrine resistance
… c-Myc expression may mediate antioestrogen resistance. However, studies of c-Myc protein expression as either a prognostic or predictive marker in human breast cancer have been limited and contradictory, as have been studies of c-Myc expression during breast cancer evolution. In order to …
-
NOVEL HER2 MUTATIONS CONFER ENDOCRINE RESISTANCE IN ER+ HER2- BREAST CANCER
… are found to be estrogen receptor (ER) positive. Endocrine therapy is the foundation of the standard of care for ER+ breast cancer patients, however, resistance to endocrine therapy is commonplace in clinical settings. We previously identified the second major mechanism of clinical endocrine …
-
COUP-TFII and its interacting proteins in breast cancer and endocrine resistance.
… or repressor. COUP-TFII expression is reduced in endocrine-resistant breast cancer cells and overexpression of COUP-TFII restores the ability of antiestrogens to inhibit cell proliferation. In this study, I tested the hypothesis that the activity of COUP-TFII in maintenance of endocrine …
-
Epigenetic mechanisms of acquired endocrine resistance in an in vitro model of breast cancer
… investigated epigenetic mechanisms of acquired endocrine-resistance in breast cancer using an in vitro model system based on estrogen-dependent MCF7 cells and their derivatives, LCC1 and LCC9. LCC1 cells, derived from MCF7 after passage in ovariectomised mice and routinely cultured in vitro in …
-
Genetic and Epigenetic Mechanisms of Endocrine Resistance in ER+ Breast Cancer: Response to SERDs and RTK-Mediated Transcriptional Rewiring
… ER+ breast cancer is typically treated with endocrine therapy, but in ~40% of cases, resistance to these therapies develops. The largest known mechanism of resistance is alterations in ER (ERmuts) accounting for ~18% of cases. Our lab previously identified the second major mechanism of …
-
Regulation of estrogen receptor-alpha mediated gene expression and endocrine resistance through estrogen receptor-alpha phosphorylation and micro-RNA in breast cancer
… of human breast cancer and the development of resistance to endocrine therapies are thought to be associated with ER phosphorylation. We generated multiple combinations of ER phospho-mutants, at residues serine 104, 106, 118, 167, 236, and 305, and examined their impact on receptor half-life, …
-
Targeting the androgen receptor in breast cancer
… all primary ER+ tumours will ultimately develop endocrine-resistance and progress on ER-targeted therapies resulting in disease-related morbidity. As a result, there is an urgent medical need for novel therapeutic strategies capable of managing endocrine-resistant breast cancer. Androgen receptor …
-
Modification of oestrogen signalling during the acquisition of hormone resistance in breast cancer cells
… much interest as a potential therapeutic target. Endocrine agents, such as tamoxifen, have been developed to reverse oestrogen (E2) stimulated gene transcription and tumour growth, however progression to endocrine resistance provides a major obstacle in breast cancer treatment. This study …
-
An Investigation into the Role of 27-Hydroxycholesterol and Estrogen Receptors in Adipose Tissue, Obesity, and Breast Cancer
… of cancer-related deaths among women worldwide. Endocrine resistance in breast cancer which occurs after endocrine therapies, causes the tumors to relapse after years of dormancy. While estrogen receptors (ERs) mutations and malfunctions of other signaling pathways (e.g., MAPK signaling) are some …
-
Investigation of phosphoserine aminotransferase 1(PSAT1) in breast cancer progression.
… negative breast cancer (TNBC) metastasis and endocrine resistance in estrogen receptor positive breast cancer (ER+BC). Breast cancer is the most common tumor diagnosis among women. While the overall 5-year survival for breast cancer is reaching 90%, the 5-year survival for metastatic disease …
-
Identification of a Novel Class of ER-Selective Ligands Lacking Cross-Reactivity to GPER
… to contribute to clinically observed endocrine resistance in breast cancer, highlighting the potential benefit of truly ER‑selective antagonists. We report the identification of a novel class of ER‑selective ligands that lack cross‑reactivity towards GPER, identifying a truly …
-
MECHANISMS OF EPIGENETIC REGULATION IN HORMONE-DRIVEN CANCERS AND DEVELOPMENT
… in metastatic ER+ disease and associated with endocrine resistance, yet its role in epithelial identity remains incompletely understood. Using in vivo mouse models, 3D organoids, single cell multiomics, and CUT&RUN, we demonstrate that Arid1a promotes luminal lineage identity and proper …
-
MECHANISMS OF RESISTANCE IN ESTROGEN RECEPTOR ALPHA POSITIVE BREAST CANCER
… development of novel therapeutic treatments for endocrine resistant estrogen receptor alpha positive (ER+) breast cancer (BC) patients. While new therapies, such as cyclin D1-CDK4/6 inhibitors, are extremely beneficial to combat endocrine resistance, a better understanding of endocrine resistance …
-
PHENOTYPIC CHARACTERIZATION OF NOVEL HER2 MISSENSE MUTANTS AND INVESTIGATING THE ROLE OF INFLAMMATORY SIGNALING IN ER+ ADVANCED BREAST CANCER
Endocrine resistance is the major challenge in treating patients with advanced estrogen receptor-positive (ER+) breast cancer. The gaining of HER2-activating mutations is one of the mechanisms that confer endocrine resistance (Nayar et al., 2018). Knowledge about the phenotype of HER2 alterations …
-
Molecular Characterization of Liver X Receptor Modulators in Luminal Breast Cancer
… oncogenic driver in ER-positive breast cancer. Endocrine therapy, such as tamoxifen, effectively disrupts ER-dependent tumorigenesis and is commonly utilized as first-line therapy. However, the development of endocrine resistance in a subset of patients remains a critical concern. This …
-
Investigating the Role of Androgen Receptor Signalling in Oestrogen Receptor Positive Breast Cancer
… receptor α (ERα) positive, and sensitive to endocrine therapies (antioestrogens and aromatase inhibitors). Endocrine therapies for ERα-positive disease are effective initially, but often fail and the disease progresses to the endocrine resistant stage, for which few therapeutic options exist. …
-
Role of MIR-29B-1 and MIR-29A in endocrine-resistant breast cancer.
… ERα. Unfortunately, the effectiveness of endocrine therapies is limited as ~ 40% of breast cancer patients will eventually acquire resistance to them. The role of miRNAs in the progression of endocrine-resistant breast cancer is of keen interest in developing biomarkers and therapies to …
Page 1 of 3